The total return over the past 12 months is +84.95% vs. +19.98% for the S&P 500. So far it's up +44.93% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +78.93% | +10.99% | +14.23% | +9.61% | +11.13% | +6.97% |
| Total Return CAGR | +84.95% | +14.46% | +17.84% | +13.02% | +14.80% | +10.71% |
| Revenue CAGR | +4.24% | +4.42% | +7.87% | +5.35% | +2.34% | +5.59% |
| Net Income CAGR | (80.66%) | (12.69%) | +20.90% | (4.70%) | (1.93%) | (2.77%) |
| EPS CAGR | (80.62%) | +8.40% | +21.21% | +16.39% | +24.28% | +6.40% |
| Free Cash Flow CAGR | +9.11% | +14.05% | +23.61% | +5.00% | +3.92% | +4.39% |
| Operating Cash Flow CAGR | +7.73% | +9.82% | +13.81% | +5.84% | +4.24% | +4.68% |
| Dividends CAGR | +5.13% | +5.41% | +6.75% | +6.62% | +5.59% | +4.16% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Merck & Co., Inc. (MRK)
| Year | Start price | End price | MRK Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $105.26 | $150.33 | +44.93% | +13.55% | +31.38% |
| 2025 | $99.48 | $105.26 | +9.78% | +17.72% | (7.94%) |
| 2024 | $109.02 | $99.48 | (6.26%) | +24.89% | (31.15%) |
| 2023 | $110.95 | $109.02 | +1.00% | +26.19% | (25.19%) |
| 2022 | $76.64 | $110.95 | +49.38% | (18.17%) | +67.55% |
| 2021 | $78.00 | $76.64 | +1.81% | +28.74% | (26.93%) |
| 2020 | $86.72 | $78.00 | (7.21%) | +18.37% | (25.58%) |
| 2019 | $72.86 | $86.72 | +22.26% | +31.22% | (8.96%) |
| 2018 | $53.65 | $72.86 | +40.01% | (4.56%) | +44.57% |
| 2017 | $56.13 | $53.65 | (1.47%) | +21.70% | (23.17%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
